Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.200
-0.130 (-3.00%)
At close: Nov 11, 2026, 4:00 PM EST
4.200
0.00 (0.00%)
After-hours: Nov 11, 2026, 4:10 PM EST
Camp4 Therapeutics Employees
Camp4 Therapeutics had 48 employees as of December 31, 2025. The number of employees decreased by 7 or 12.73% compared to the previous year. That makes Camp4 Therapeutics the 35,139th largest employer in the world and 4,697th in the United States.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$110,833
Profits / Employee
-$2,522,938
Market Cap
263.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 48 | -7 | -12.73% |
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Sep 30, 2024 | 53 | -11 | -17.19% |
| Jun 30, 2024 | 58 | - | - |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 206 |
| Rocket Pharmaceuticals | 202 |
| Nautilus Biotechnology | 128 |
| SAB Biotherapeutics | 86 |
| Scribe Therapeutics | 82 |
| Vicore Pharma Holding AB | 40 |
| Inhibikase Therapeutics | 35 |
| Q32 Bio | 25 |
CAMP News
- 1 day ago - Camp4 Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 2 days ago - Camp4 Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 6 days ago - Camp4 Therapeutics reports Q3 EPS (37c), consensus (22c) - TheFly
- 6 days ago - CAMP4 Reports Third Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 6 days ago - Camp4 Therapeutics Quarterly report: Q3 2026 - Filings
- 6 days ago - Camp4 Therapeutics Earnings release: Q3 2026 - Filings
- 15 days ago - Camp4 Therapeutics receives CTA approval for CMP-002 in the European Union - TheFly
- 15 days ago - CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union - GlobeNewsWire